Chris Dunn
Overview
Explore the profile of Chris Dunn including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
858
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Banta-Green C, Coffin P, Merrill J, Sears J, Dunn C, Floyd A, et al.
Inj Prev
. 2018 Feb;
25(3):191-198.
PMID: 29436397
Background: Opioid overdose is a major and increasing cause of injury and death. There is an urgent need for interventions to reduce overdose events among high-risk persons. Methods: Adults at...
2.
McDonell M, West I, Ries R, Donovan D, Bumgardner K, Dunn C, et al.
J Addict Med
. 2017 May;
11(3):243.
PMID: 28557962
No abstract available.
3.
Steele J, Fisher J, Skivington M, Dunn C, Arnold J, Tew G, et al.
BMC Public Health
. 2017 Apr;
17(1):300.
PMID: 28381272
It is well known that physical activity and exercise is associated with a lower risk of a range of morbidities and all-cause mortality. Further, it appears that risk reductions are...
4.
Dunn C, Darnell D, Yi S, Steyvers M, Bumgardner K, Lord S, et al.
Motiv Interviewing
. 2016 Sep;
1(3):38-41.
PMID: 27595051
Standardized rating systems are often used to evaluate the proficiency of Motivational Interviewing (MI) counselors. The published inter-rater reliability (degree of coder agreement) in many studies using these instruments has...
5.
McDonell M, Graves M, West I, Ries R, Donovan D, Bumgardner K, et al.
J Addict Med
. 2016 May;
10(3):196-201.
PMID: 27159345
Objectives: To determine if urine drug tests (UDTs) can detect under-reporting of drug use (ie, negative self-report, but positive UDT) and identify patient characteristics associated with underreporting when treating substance...
6.
Dunn C, Darnell D, Atkins D, Hallgren K, Imel Z, Bumgardner K, et al.
J Subst Abuse Treat
. 2016 Mar;
65:74-82.
PMID: 27016875
This study examined variability in Motivational Interviewing (MI) integrity among 15 providers for three years following training. Data come from an effectiveness trial in which providers were trained to deliver...
7.
8.
Ries R, Krupski A, West I, Maynard C, Bumgardner K, Donovan D, et al.
J Addict Med
. 2015 Oct;
9(5):417-26.
PMID: 26428361
Objectives: The purpose of this study was to compare demographic, clinical, and survival characteristics of drug-using safety-net primary care patients who used or did not use opioids, and to examine...
9.
Roy-Byrne P, Maynard C, Bumgardner K, Krupski A, Dunn C, West I, et al.
Am J Addict
. 2015 Sep;
24(7):599-606.
PMID: 26337603
Background And Objectives: Marijuana is currently approved for medical use in 23 states. Both clinicians and the lay public have questioned whether users of marijuana for medical purposes are different...
10.
Dunn C, Darnell D, Carmel A, Atkins D, Bumgardner K, Roy-Byrne P
J Subst Abuse Treat
. 2014 Dec;
51:47-52.
PMID: 25515624
This quasi experimental study compared the motivational interviewing (MI) integrity in two prevalent brief intervention (BI) service delivery models for drug abuse. Routine primary care providers (RCPs) and non-routine care...